BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260604T160000
DTEND;TZID=America/New_York:20260604T183000
DTSTAMP:20260522T082523Z
CREATED:20260430T154259Z
LAST-MODIFIED:20260522T082523Z
UID:10312-1780588800-1780597800@thebiocalendar.com
SUMMARY:BVS' Summer Biotech Community Celebration at Tech Square\, Cambridge
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at Tech Square. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nAll the biotech tenants at 100-700 Technology Square and other companies in the Cambridge vicinity are invited to attend this event. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Food & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions\,etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-summer-biotech-community-celebration-at-tech-square-cambridge-3/
LOCATION:Cambridge\, MA\, Cambridge\, MA\, 02139\, United States
CATEGORIES:Expo,Networking
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/04/BVS-Biotech-Event-Flyer-06-04-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T110000
DTEND;TZID=America/Los_Angeles:20260604T120000
DTSTAMP:20260522T082550Z
CREATED:20260512T142112Z
LAST-MODIFIED:20260522T082550Z
UID:10436-1780570800-1780574400@thebiocalendar.com
SUMMARY:Beyond Data Packages: Derisking Tech Transfer To CDMOs
DESCRIPTION:Technology transfer to a CDMO is rarely as simple as handing over a data package. From documentation gaps and equipment differences to method variability and global standards\, many programs encounter avoidable risks that can derail timelines and increase cost. In this Outsourced Pharma Live session\, industry experts share practical strategies to help sponsors better prepare for tech transfer and align more effectively with CDMO partners. \nJoin us to learn how tools like smarter documentation systems\, design of experiments\, and in silico modeling can support stronger CMC alignment and improve the likelihood of a right-first-time transfer—across small molecules\, biologics\, and advanced therapies.
URL:https://thebiocalendar.com/event/beyond-data-packages-derisking-tech-transfer-to-cdmos/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_06-OPL-HTML-600x300-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T110000
DTEND;TZID=America/Los_Angeles:20260604T120000
DTSTAMP:20260522T082619Z
CREATED:20260506T133246Z
LAST-MODIFIED:20260522T082619Z
UID:10374-1780570800-1780574400@thebiocalendar.com
SUMMARY:Helping ensure safer immunotherapies: From gene editing to next-generation sequencing (NGS)-based T cell characterization
DESCRIPTION:Immune checkpoint inhibitors have transformed cancer treatment\, but response rates remain limited\, and immune-related toxicities continue to pose challenges. Gene editing of therapeutic T cells offers a promising path to help enhance specificity and safety by directly modulating checkpoint expression. \nIn this webinar\, we explore how gene-edited T cells targeting PD-1 and TIGIT can improve anti-tumor activity\, based on preclinical models and ongoing translational research. We will present how tumor-infiltrating lymphocytes (TILs) derived from melanoma metastases are engineered\, expanded and functionally characterized to assess their therapeutic potential. \nBeyond the biology\, this session highlights the critical role of integrated genomic workflows in enabling these insights. From high-quality nucleic acid extraction to next-generation sequencing (NGS)-based transcriptomic profiling\, we highlight how automated\, high-throughput sample preparation and NGS downstream analysis enable reliable identification of gene expression changes driving T cell function and efficacy. \nJoin us to learn how combining advanced cell engineering with end-to-end genomic solutions can accelerate cell therapy discovery and lead selection\, bridging the gap between experimental design and actionable insight. \nLearning objectives:\n~ Understand how gene editing of immune checkpoints (PD-1\, TIGIT) can enhance T cell–based cancer therapies\n~ Learn how integrated workflows\, from automated\, high-throughput nucleic acid extraction to NGS\, enable high-quality\, reproducible transcriptomic insights\n~ Discover how genomic data can inform functional characterization and support cell therapy\, lead discovery and development
URL:https://thebiocalendar.com/event/helping-ensure-safer-immunotherapies-from-gene-editing-to-next-generation-sequencing-ngs-based-t-cell-characterization/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-04-26-Qiagen-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T110000
DTEND;TZID=America/Los_Angeles:20260604T120000
DTSTAMP:20260522T082702Z
CREATED:20260417T125838Z
LAST-MODIFIED:20260522T082702Z
UID:10226-1780570800-1780574400@thebiocalendar.com
SUMMARY:Supporting Efficient mAb Development with a Flexible Downstream Purification Toolkit
DESCRIPTION:Bringing innovative antibody therapeutics to market quickly requires more than upstream efficiency. It demands adaptable and robust downstream purification strategies. \nAs novel mAb formats increase in complexity\, purification challenges grow. Achieving required purity and yield often extends beyond traditional 2–3 step platform processes\, requiring expanded chromatography options and optimized buffer systems. \nIn this webinar\, we will discuss: \n– Practical strategies for designing a flexible downstream purification toolkit\n– Approaches to buffer optimization for challenging antibody molecules\n– Ways to streamline process development while maintaining performance \nRegister to learn how a well-designed purification toolkit can help accelerate development timelines and improve process robustness.
URL:https://thebiocalendar.com/event/supporting-efficient-mab-development-with-a-flexible-downstream-purification-toolkit/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/06-04-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260604T080000
DTEND;TZID=America/Los_Angeles:20260604T160000
DTSTAMP:20260521T154519Z
CREATED:20260521T154458Z
LAST-MODIFIED:20260521T154519Z
UID:10503-1780560000-1780588800@thebiocalendar.com
SUMMARY:2026 Life Sciences Workforce Conference
DESCRIPTION:MassBioEd’s Annual Life Science Workforce Conference brings together representatives from the life sciences industry\, academic institutions\, training providers\, government and community to explore key issues and strategies in building a strong life science workforce in Massachusetts. \nThe 2026 Life Sciences Workforce Conference: Building Talent Pathways in a Dynamic Time: Massachusetts Prepares the Future Workforce will be held on \nJune 4th at Boston University
URL:https://thebiocalendar.com/event/2026-life-sciences-workforce-conference/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Networking,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260604
DTEND;VALUE=DATE:20260606
DTSTAMP:20260527T225156Z
CREATED:20260527T225156Z
LAST-MODIFIED:20260527T225156Z
UID:10521-1780531200-1780703999@thebiocalendar.com
SUMMARY:Medical Device & Digital Health Conference
DESCRIPTION:Join us for our 33rd Annual MDC\, which features engaging panel sessions and keynote addresses\, a Partnering Hall connecting attendees with start-ups and investors from around the globe\, the MedTech Innovator pitch event\, and a lively wine tasting reception where venture capitalists serve as sommeliers.
URL:https://thebiocalendar.com/event/medical-device-digital-health-conference/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260604
DTEND;VALUE=DATE:20260606
DTSTAMP:20260501T115308Z
CREATED:20260501T115308Z
LAST-MODIFIED:20260501T115308Z
UID:10322-1780531200-1780703999@thebiocalendar.com
SUMMARY:NYC AI x Longevity Summit
DESCRIPTION:Dive into the future of aging with cutting-edge AI breakthroughs at this can’t-miss summit! \n\n\n\n\nJune 4–5\, 2026 | BioLabs@NYU Langone\, Long Island City\, Queens \nLongevity science is at an inflection point. Foundation models are learning the language of biology\, aging clocks are quantifying human health with new precision\, and a generation of therapeutics and clinical platforms is emerging to act on those signals. \nThe inaugural theme of the Summit\, Signal to Intervention\, explores how AI is compressing the distance between discovery and real-world impact. \nAs a flagship event of Longevity Global NYC\, the AI x Longevity Summit convenes the researchers\, clinicians\, founders\, and engineers building the next generation of longevity infrastructure. Hosted at BioLabs@NYU Langone in the heart of the city’s biotech corridor\, the Summit is where technical depth meets translational ambition.
URL:https://thebiocalendar.com/event/nyc-ai-x-longevity-summit/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260603T110000
DTEND;TZID=America/Los_Angeles:20260603T120000
DTSTAMP:20260522T082729Z
CREATED:20260512T141741Z
LAST-MODIFIED:20260522T082729Z
UID:10432-1780484400-1780488000@thebiocalendar.com
SUMMARY:Faster Clones\, Simpler Process: What’s Changing in CHO Expression?
DESCRIPTION:CHO expression continues to evolve\, and recent advances are reshaping how quickly and efficiently high-performing cell lines are developed. In this webinar\, experts explore the latest innovations in the GS® Expression System\, highlighting how advanced vector design\, stronger selection stringency\, and enhanced promoter control are driving higher titers\, more stable pools\, and faster timelines from DNA to lead clone. \nKey Learning Objectives:\n– Understand the critical design elements of CHO expression vectors\n– Explore the development and performance advantages of improved glutamine synthetase selection stringency\n– Discover emerging data driven strategies for improving gene expression control in CHO cells
URL:https://thebiocalendar.com/event/faster-clones-simpler-process-whats-changing-in-cho-expression-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-03-26-Lonza-eblast-700x200-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260603T110000
DTEND;TZID=America/New_York:20260603T120000
DTSTAMP:20260526T212820Z
CREATED:20260428T162322Z
LAST-MODIFIED:20260526T212820Z
UID:10268-1780484400-1780488000@thebiocalendar.com
SUMMARY:Hidden in Plain Sight: How Solid-State Science Solves Your Toughest API Challenges
DESCRIPTION:This webinar series explores two powerful\, complementary disciplines that CDMOs leverage to tackle these challenges head-on. First\, we examine the solid-state domain\, exploring how targeted crystallization development can directly address purification\, filtration\, stability\, and processability challenges from lab scale through commercialization. Then\, we see how chromatographic modeling tools in combination with innovative techniques like “fraction mapping\,” can improve efficiency\, recovery\, and purity across various scales
URL:https://thebiocalendar.com/event/hidden-in-plain-sight-how-solid-state-science-solves-your-toughest-api-challenges/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/06-03-26-MilliporeSigma-Reg-1920x250-PART-ONE.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260603T100000
DTEND;TZID=America/New_York:20260603T110000
DTSTAMP:20260529T171519Z
CREATED:20260428T174731Z
LAST-MODIFIED:20260529T171519Z
UID:10272-1780480800-1780484400@thebiocalendar.com
SUMMARY:2026 Manufacturing Trends Reshaping Life Sciences: AI\, Integration\, and Workforce Readiness
DESCRIPTION:The webinar also highlights the growing role of AI within regulated manufacturing environments. Rather than treating AI as an add-on\, the session outlines how to embed it into validated frameworks to support predictive maintenance\, yield optimization\, and faster product release cycles.
URL:https://thebiocalendar.com/event/2026-manufacturing-trends-reshaping-life-sciences-ai-integration-and-workforce-readiness-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/06-03-26-MasterControl-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260603T083000
DTEND;TZID=America/Los_Angeles:20260603T150000
DTSTAMP:20260419T120546Z
CREATED:20260419T120546Z
LAST-MODIFIED:20260419T120546Z
UID:10231-1780475400-1780498800@thebiocalendar.com
SUMMARY:Better Together: A Pharma & Biotech EHS Forum
DESCRIPTION:Reimagine what’s possible—together.\nJoin BSI Consulting for an expert-led forum designed for pharma and biotech professionals who are shaping the next era of EHS. Connect with peers\, challenge assumptions\, and explore practical solutions to the industry’s most pressing risks and opportunities. \nThis event brings together leaders at the forefront of life sciences in EHS to learn\, debate\, and reimagine what’s possible. \nFeaturing speakers from:  \nAstraZeneca · Intellia Therapeutics · Leading multinational biotech organizations · BSI Consulting \nWhat you’ll experience\nDuring this one-day event\, you’ll be part of conversations that matter. \nKeynote spotlight: AI Large and Small  \nHear from an AI practitioner on the types of automation systems to support problem-solving\, and the opportunities and limitations of AI use. \nMulti-track roundtables with leading organizations  \nJoin guest speakers and BSI Consulting as they explore: \n\nBridging competency gaps across EHS teams.\nUnseen risks of waste misclassification in labs and R&D environments.\nAI governance\, compliance\, and date integrity in life sciences.\nBuilding biosafety systems that move beyond minimum compliance.\nSupply chain risk – details to be announced soon! \n\nInteractive discussions \nCollaborate in facilitated groups to identify shared industry challenges and co-create actionable solutions. \nYou’ll walk away with new relationships\, practical insights\, and a renewed sense of purpose in your work. \nView the full agenda!
URL:https://thebiocalendar.com/event/better-together-a-pharma-biotech-ehs-forum/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260603
DTEND;VALUE=DATE:20260605
DTSTAMP:20260504T221221Z
CREATED:20260504T221221Z
LAST-MODIFIED:20260504T221221Z
UID:10332-1780444800-1780617599@thebiocalendar.com
SUMMARY:The Festival of Genomics\, Biodata & AI
DESCRIPTION:From data to decisions. From discovery to better patient outcomes. \n\n\nThe Festival of Genomics\, Biodata & AI returns to Boston at a critical moment for the US life sciences community. Funding pressures\, rising development costs and intensifying competition are colliding with an unprecedented opportunity: the convergence of multi-omics\, large-scale biodata and artificial intelligence. \nTo stay ahead\, organizations must do more than generate data – they must integrate technologies\, break down silos and translate insight into measurable progress\, in research\, drug discovery and translation into the clinic.
URL:https://thebiocalendar.com/event/the-festival-of-genomics-biodata-ai/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Forum,Symposium
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260603
DTEND;VALUE=DATE:20260606
DTSTAMP:20260504T220856Z
CREATED:20260504T220856Z
LAST-MODIFIED:20260504T220856Z
UID:10329-1780444800-1780703999@thebiocalendar.com
SUMMARY:BioCentury Grand Rounds - U.S.
DESCRIPTION:Connecting Translational Science with the Right Partners to Advance Drug Development\nJoin VCs\, biopharma decision-makers and academic innovators in Seattle\, June 2026\, for the 3rd BioCentury Grand Rounds – U.S. \nThis R&D conference brings together leaders at the forefront of translational science to explore the breakthroughs\, bottlenecks and strategies shaping the future of drug development. \nUnlock transformative opportunities debate scientific hurdles with the innovators driving biopharma advancements \nDiscover cutting-edge science with commercial potential \nGain industry insights through presentations by emerging biotechs and academic innovators \nSchedule partnering meetings with VCs\, pharmas and leading academics
URL:https://thebiocalendar.com/event/biocentury-grand-rounds-u-s/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260602T163000
DTEND;TZID=America/Los_Angeles:20260602T190000
DTSTAMP:20260522T082825Z
CREATED:20260428T142837Z
LAST-MODIFIED:20260522T082825Z
UID:10260-1780417800-1780426800@thebiocalendar.com
SUMMARY:BVS' Biotech Community Event at SOVA Science District\, San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. \nThis is a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nOur last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \n✨ What to Expect: \nVendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nDelicious Tacos & Beer: Enjoy delicious Tacos as you network and explore the vendor exhibits. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions\,etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-sova-science-district-san-diego-10/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Expo,Networking
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/04/BVS-Biotech-Event-Flyer-06-2-26.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260602T110000
DTEND;TZID=America/Los_Angeles:20260602T120000
DTSTAMP:20260522T082847Z
CREATED:20260506T180650Z
LAST-MODIFIED:20260522T082847Z
UID:10391-1780398000-1780401600@thebiocalendar.com
SUMMARY:From Complexity to Confidence: Supporting Tech Transfer with a Prefillable Syringe System
DESCRIPTION:This webinar shows how a system-based primary packaging approach—like the West Synchrony™ prefillable syringe system—can streamline tech transfer\, simplify GMP qualification\, and reduce complexity\, cost\, and timelines for injectable drug manufacturing. \nKey Learning Objectives:\n– How injectable technology transfer impacts project timelines\, cost\, and risk when working with a CDMO\n– Where primary packaging decisions intersect with tech transfer activities and why early alignment matters\n– How a system-based approach to prefillable syringe packaging can reduce complexity during tech transfer\n– How the West Synchrony™ S1 prefillable syringe system supports a more streamlined\, turnkey tech transfer with CDMO partners
URL:https://thebiocalendar.com/event/from-complexity-to-confidence-supporting-tech-transfer-with-a-prefillable-syringe-system/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-02-26-West-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260602T110000
DTEND;TZID=America/Los_Angeles:20260602T120000
DTSTAMP:20260522T082910Z
CREATED:20260506T180207Z
LAST-MODIFIED:20260522T082910Z
UID:10387-1780398000-1780401600@thebiocalendar.com
SUMMARY:Addressing Manufacturing and Characterization Challenges and Opportunities with Novel AAV Capsids
DESCRIPTION:Join Viralgen\, Genosafe and DarkHorse Consulting as they discuss their experience with novel capsid manufacturing\, analytical testing and regulatory guidance. \nKey learning objectives:\n– Ways to address the complexity of novel capsid manufacturing\n– Approaches to consider with the analytical testing of novel capsids\n– Regulatory considerations around novel capsids
URL:https://thebiocalendar.com/event/addressing-manufacturing-and-characterization-challenges-and-opportunities-with-novel-aav-capsids/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-02-26-Viralgen-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260602T110000
DTEND;TZID=America/Los_Angeles:20260602T120000
DTSTAMP:20260522T082937Z
CREATED:20260505T144223Z
LAST-MODIFIED:20260522T082937Z
UID:10362-1780398000-1780401600@thebiocalendar.com
SUMMARY:Advancing Next Gen Antibodies and ADCs: From AI Driven Cell Line Development to Integrated Manufacturing
DESCRIPTION:Antibody-drug conjugate (ADC) development continues to evolve\, with increased molecular complexity leading to new opportunities and challenges across design\, development\, and manufacturing. The industry is advancing novel technologies to support these next-generation antibody therapies and is adopting workflows better suited to their unique development considerations. \nIn this webinar\, we will examine how development teams address these challenges through more integrated and data driven CMC strategies. We will focus on how AI driven cell line development is enabling faster clone selection\, improved productivity\, and earlier insight into product quality risks. We will cover key considerations from early process development through scale up and manufacturing and how these approaches enable consistency\, efficiency\, and commercialization readiness\, with insights applicable to emerging formats such as multi-specific antibodies and ADCs. \nThe session will conclude with perspectives on the future of ADC manufacturing and bioproduction for complex molecules. It will highlight how AI\, bioprocess integration\, and digital connectivity may enable more predictive development and integrated manufacturing platforms. Attendees will gain insight into how emerging technologies can help de risk next generation programs while accelerating timelines and supporting long term manufacturing readiness. \nKey Learning Objectives\n~ Understand how increasing molecular complexity is reshaping CMC requirements across the development and manufacturing lifecycle\n~ Learn how AI driven cell line development and robust manufacturing strategies are enabling more efficient and robust development and control of critical quality attributes\n~ Explore future manufacturing paradigms for antibody-based therapeutics
URL:https://thebiocalendar.com/event/advancing-next-gen-antibodies-and-adcs-from-ai-driven-cell-line-development-to-integrated-manufacturing/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-02-26-Cytiva-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260602T100000
DTEND;TZID=America/Los_Angeles:20260602T170000
DTSTAMP:20260514T171303Z
CREATED:20260507T180711Z
LAST-MODIFIED:20260514T171303Z
UID:10401-1780394400-1780419600@thebiocalendar.com
SUMMARY:Breakthroughs in Bioprocessing
DESCRIPTION:At Breakthroughs in Bioprocessing\, you’ll have the opportunity to: \n\nTranslate expertise into impact\nWork alongside Cytiva specialists and industry peers to explore practical\, scalable approaches across bioprocess development\, manufacturing\, and scale-up.\nExperience innovation beyond theory\nEngage with advanced technologies in a live\, interactive environment designed to support hands-on learning and real-world application.\nGain insight through shared experience\nLearn from industry perspectives and peer-to-peer discussion\, with dedicated time for questions\, dialogue\, and meaningful networking.\n\nThe event is designed for professionals working in: \n\nProcess development\nManufacturing and scale-up\nMSAT and operations\nBioprocess innovation and optimization\n\nIf you’re looking for practical insight and peer exchange focused on real world challenges\, this event is for you.
URL:https://thebiocalendar.com/event/breakthroughs-in-bioprocessing/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Forum,Networking,Presentation
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260602T080000
DTEND;TZID=America/Los_Angeles:20260602T123000
DTSTAMP:20260327T140751Z
CREATED:20260327T140751Z
LAST-MODIFIED:20260327T140751Z
UID:10107-1780387200-1780403400@thebiocalendar.com
SUMMARY:Boston Life Sciences Conference
DESCRIPTION:What You’ll Learn: \n\nHow does life sciences continue to be Boston’s and Cambridge’s economic engine amid a softening market?\nWith total VC investment at $6.85B across 197 rounds in 2025\, is capital concentrating into fewer winners\, and how is that changing tenant decision making?\nWhere are AI enabled life sciences users\, automation heavy labs\, and data driven R and D teams showing up in Cambridge and Greater Boston?\nHow have significant projects in the area played a role in shaping the growth and development of the biotechnology and life science sectors?\nWhich incentives\, workforce programs\, and state tools are still available to support expansions and manufacturing growth in Massachusetts?\nWith Greater Boston lab vacancy at 28.0% in Q4 2025\, what is the realistic timeline and mechanism for absorption?\nWhat types of tenants are active in the market right now for space\, and what kind of space are they leasing up? \nWhat product is winning leasing right now: incubator\, flex lab\, mid scale growth space\, or larger HQ and R&D?\n\nHow you’ll do more business: \nConnect with industry leaders to explore emerging leasing dynamics and market trends\, and gain valuable insights on the current state of the sector. Discover cutting-edge innovations in workplace flexibility and design. Explore topics like sustainable facility design\, power solutions and access considerations and other crucial aspects that can enhance your business strategy.  \nWho attends: \nInvestors\, owners\, developers\, tenants\, end users\, brokers\, lawyers\, designers\, contractors\, architects\, property managers and more! \nWhy should you attend: \nBisnow events bring together the biggest power players in the industry to identify opportunities\, build your network\, and expand your business. With the largest audience of commercial real estate professionals in the world\, no one knows how to help your business more than us.
URL:https://thebiocalendar.com/event/boston-life-sciences-conference-2/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260604
DTSTAMP:20260504T221327Z
CREATED:20260504T221327Z
LAST-MODIFIED:20260504T221327Z
UID:10333-1780358400-1780531199@thebiocalendar.com
SUMMARY:Future BioTech Expo
DESCRIPTION:Future BioTech Expo is a purpose built international exhibition and conference dedicated to red biotechnology and the science transforming how we prevent\, diagnose\, and treat disease.\nHeld at the Hilton Houston North on June 2–3\, 2026\, #FBE26 unites pharma innovators\, clinical researchers\, biotech CEOs\, investors\, and policymakers under one roof in one of America’s fastest growing life sciences cities. This isn’t just any other industry event. It’s a focused\, high signal environment built for deals\, discovery\, and long term partnerships.
URL:https://thebiocalendar.com/event/future-biotech-expo/
LOCATION:Houston\, Houston\, TX\, 77001\, United States
CATEGORIES:Expo
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260605
DTSTAMP:20260415T152610Z
CREATED:20260415T152522Z
LAST-MODIFIED:20260415T152610Z
UID:10200-1780358400-1780617599@thebiocalendar.com
SUMMARY:Global Healthcare Conference in New York
DESCRIPTION:By invitation only.  You must be pre-registered by your Jefferies representative in order to attend. \nThe Jefferies Global Healthcare Conference in New York will take place on Tuesday\, June 2 – Thursday June 4\, 2026. This year’s conference will focus on life sciences companies in the biotechnology\, life sciences tools and services\, medical technology\, and pharmaceutical sectors. \nWe will dedicate Tuesday\, June 2 to private companies only. The format will consist of 1x1s and small group meetings between select private companies and investors. There will be no presentations.  On Wednesday\, June 3 & Thursday\, June 4\, we will host over 300 public companies for two full days of presentations\, fireside chats\, 1x1s and small group meetings. \nWe look forward to organizing another exciting conference\, as we bring together over 3\,000 leading executives\, institutional investors\, private equity investors & VCs to address near- and long-term investment opportunities and discuss the current trends driving healthcare in the U.S. and internationally.
URL:https://thebiocalendar.com/event/global-healthcare-conference-in-new-york/
LOCATION:New York\, New York\, NY\, United States
CATEGORIES:Investor
ATTACH;FMTTYPE=image/webp:https://thebiocalendar.com/wp-content/uploads/2026/04/Global-HC-Conf-New-York-2026-Web-Tile-1200x490px-300dpi.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260601T110000
DTEND;TZID=America/Los_Angeles:20260601T120000
DTSTAMP:20260522T082957Z
CREATED:20260512T140839Z
LAST-MODIFIED:20260522T082957Z
UID:10420-1780311600-1780315200@thebiocalendar.com
SUMMARY:From Design to Industrial Scale: Key Technical Challenges in Recombinant Protein Development
DESCRIPTION:Taking a recombinant protein from milligrams to GMP-ready scale is where development programs truly succeed or fail. Join this expert-led webinar to explore the critical decision points that impact scalability\, quality\, CMC readiness\, and time to clinic\, with real-world insights you can apply immediately. \nKey learning objectives:\n– Navigate expression system selection (microbial\, mammalian and key variants) based on molecule complexity\, quality targets\, productivity\, and downstream/CMC impact\n– Translate lab-scale success into industrial scale-up by anticipating scale-dependent risks\n– Spot and de-risk the most common CMC bottlenecks for recombinant proteins\, including analytical approach\, comparability\, impurity control strategy\, stability/formulation\, and expectations related to GMP documentation
URL:https://thebiocalendar.com/event/from-design-to-industrial-scale-key-technical-challenges-in-recombinant-protein-development-2/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/06-01-26-3P-Biovian-eBlast-700x200-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260530
DTEND;VALUE=DATE:20260603
DTSTAMP:20260506T134225Z
CREATED:20260506T134225Z
LAST-MODIFIED:20260506T134225Z
UID:10379-1780099200-1780444799@thebiocalendar.com
SUMMARY:SNMMI Annual Meeting 2026
DESCRIPTION:Why Attend \nThe 2026 SNMMI Annual Meeting will feature: \n\nRevolutionary research shaping the future of nuclear medicine and molecular imaging\nAdvanced clinical applications transforming patient care\nUnparalleled networking opportunities with global thought leaders\n\n\n\n\n\n\n\nWho Should Attend? \nThe 2026 SNMMI Annual Meeting will feature groundbreaking research and clinical innovation. This critical event unites physicians\, technologists\, pharmacists\, laboratory professionals\, scientists\, and industry to showcase cutting-edge developments accelerating the path to better patient care.
URL:https://thebiocalendar.com/event/snmmi-annual-meeting-2026/
LOCATION:Los Angeles\, Los Angeles\, CA\, United States
CATEGORIES:Annual Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260529T110000
DTEND;TZID=America/Los_Angeles:20260529T120000
DTSTAMP:20260522T083038Z
CREATED:20260429T155001Z
LAST-MODIFIED:20260522T083038Z
UID:10304-1780052400-1780056000@thebiocalendar.com
SUMMARY:CAR-T Strategy in 2026: Scaling Autologous\, Advancing Allogeneic
DESCRIPTION:Join this thought leadership panel exploring how the CAR-T landscape continues to evolve as clinical and commercial experience grows. As autologous therapies expand into additional settings and allogeneic approaches continue to be studied\, organizations are reassessing where to focus research\, development\, and operational efforts. \nThis discussion brings together perspectives from across the cell therapy ecosystem to examine key scientific\, operational\, and market considerations shaping CAR-T development in 2026 and beyond. \nWhat you will learn:\n~ Differences in the current use and development of autologous and allogeneic CAR-T therapies\n~ Factors influencing manufacturing\, supply chain\, and clinical approaches\n~ Regulatory\, commercial\, and operational considerations\n~ Areas of ongoing development and uncertainty \nKey topics include:\n~ Modality strategy: roles of autologous vs allogeneic approaches\n~ Manufacturing: scalability\, consistency\, and process control\n~ Clinical development: expansion and durability considerations\n~ Access: reimbursement and site-of-care factors\n~ Regulatory & CMC: expectations and comparability\n~ Supply chain: patient-specific vs off-the-shelf models\n~ Collaboration: cross-sector partnership approaches \nThis panel provides perspectives on how organizations are approaching CAR-T strategy\, including near-term priorities and longer-term considerations.
URL:https://thebiocalendar.com/event/car-t-strategy-in-2026-scaling-autologous-advancing-allogeneic/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/05-29-26-Thermo-LinkedIn-1280x720-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260528T110000
DTEND;TZID=America/Los_Angeles:20260528T120000
DTSTAMP:20260522T083108Z
CREATED:20260505T144000Z
LAST-MODIFIED:20260522T083108Z
UID:10356-1779966000-1779969600@thebiocalendar.com
SUMMARY:Downstream Decisions To Maximize Vector Yields And Reduce COGs
DESCRIPTION:Gene therapies are among the most expensive biopharmaceuticals to develop and manufacture\, due in large part to persistent bottlenecks in downstream processing. When purification workflows lose 10% to 30% of vector at each unit operation\, it forces developers to make critical tradeoffs to maximize yield without compromising product quality. \nJoin Bioprocess Online on Thursday\, May 28\, at 11 a.m. Eastern for a live panel discussion with Hung Trinh\, Ph.D.\, CEO at Vertex Biopharm Consulting\, and Nathalie Clément\, Ph.D.\, senior VP of vector development at Siren Biotechnology. These experts will explore how teams are finding success overcoming challenges in downstream purification\, as well as how factors like vector type\, dose\, and route of administration can influence downstream design. \nThey will also address evolving regulatory expectations\, including recent FDA and EMA perspectives\, and what they mean for process validation\, analytics\, and commercial readiness.
URL:https://thebiocalendar.com/event/downstream-decisions-to-maximize-vector-yields-and-reduce-cogs/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_05_BPOL_LinkedIn_1280x720.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260528T110000
DTEND;TZID=America/Los_Angeles:20260528T120000
DTSTAMP:20260522T083133Z
CREATED:20260505T121715Z
LAST-MODIFIED:20260522T083133Z
UID:10346-1779966000-1779969600@thebiocalendar.com
SUMMARY:Quality by Design: The Future of Automated Pharmaceutical Labeling
DESCRIPTION:Pharmaceutical labeling continues to change and adapt to trends in product presentation & regulations. Considering trends in automation\, product handling\, and robotics\, it is important to have standardized approaches to pharmaceutical labeling platforms. Rising trends in single use autoinjector devices and personalized medicines require quality design with the future in mind. Pharmaceutical labeling machines need to ensure compatibility with future formats and this is critical to streamline production efforts. Automating labeling processes with robotics for small batches gives manufacturers greater efficiency and removes labor intensive loading and unloading\, as well as possible quality errors from manual feeding and inspection. Learn how HERMA has standard labeling platforms for small to large batch pharmaceutical production\, and everything in between. \nKey Learning Objectives:\n– Understand how Quality by Design (QbD) principles can be applied to pharmaceutical labeling to ensure scalability\, compliance\, and future format compatibility\n– Learn how automation and robotics improve efficiency\, reduce manual errors\, and support small-batch and personalized medicine production\n– Explore standardized labeling platform strategies that enable flexible deployment across varying batch sizes and product formats
URL:https://thebiocalendar.com/event/quality-by-design-the-future-of-automated-pharmaceutical-labeling/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/05-28-26-Herma-eBlast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260528T090000
DTEND;TZID=America/Los_Angeles:20260528T103000
DTSTAMP:20260506T135003Z
CREATED:20260506T135003Z
LAST-MODIFIED:20260506T135003Z
UID:10385-1779958800-1779964200@thebiocalendar.com
SUMMARY:The Art of Fundraising
DESCRIPTION:Danforth Health provides the life sciences community with strategic and operational support across business\, clinical and commercial functions. \nModerated by: Barb Carlin\, CPA\, MBA\, Managing Director\, Mid Atlantic Region\, Danforth Health \n\n 9:00 AM – 10:00 AM – Panel Discussion\n10:00 AM – 10:30 AM – Networking in Zoom Breakout Rooms\n\nQuestions? Contact Lauren Boyle\, lboyle@lifesciencespa.org
URL:https://thebiocalendar.com/event/the-art-of-fundraising-4/
LOCATION:Online webinar
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260528
DTEND;VALUE=DATE:20260603
DTSTAMP:20260311T084731Z
CREATED:20260311T084731Z
LAST-MODIFIED:20260311T084731Z
UID:10011-1779926400-1780444799@thebiocalendar.com
SUMMARY:BIO Partnering for Oncology
DESCRIPTION:Connect with innovators\, investors\, and companies advancing cancer breakthroughs\, in person or virtually\, during Chicago’s biggest oncology event through the BIO Partnering™ system.
URL:https://thebiocalendar.com/event/bio-partnering-for-oncology/
LOCATION:Chicago\, Chicago\, IL\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260527T160000
DTEND;TZID=America/Los_Angeles:20260527T183000
DTSTAMP:20260522T083202Z
CREATED:20260428T143147Z
LAST-MODIFIED:20260522T083202Z
UID:10264-1779897600-1779906600@thebiocalendar.com
SUMMARY:BVS and BioMed Realty's Biotech Community Event in SSF
DESCRIPTION:Join Us for the BVS and BioMed Realty Biotech Community Event! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThe vendor fair is held at The Forum\, in the same building as Amgen and next to Genentech\, right in the heart of the large pharma/biotechs in South San Francisco. \n✨ What to Expect: \nVendor Exhibit: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\nNetworking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\nAppetizers & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nWe welcome the entire Bay Area Biotech Community to join us for this exciting event! This is a wonderful chance for everyone to come together\, share insights\, and celebrate the vibrant biotech landscape in our region. \nAdmission Details: \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes. \n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-and-biomed-realtys-biotech-community-event-in-ssf-7/
LOCATION:South San Francisco\, CA\, CA\, 94080\, United States
CATEGORIES:Expo,Networking
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/04/Biomed-Event-Flyer-05-27-26-Flyer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260527T110000
DTEND;TZID=America/Los_Angeles:20260527T120000
DTSTAMP:20260522T083243Z
CREATED:20260504T164758Z
LAST-MODIFIED:20260522T083243Z
UID:10324-1779879600-1779883200@thebiocalendar.com
SUMMARY:Analytical Strategies for High-Volume GLP-1 Manufacturing
DESCRIPTION:This presentation focuses on the analytical strategies required to enable high-volume production\, including the deployment of high-throughput chromatographic methods for impurity profiling\, integration of orthogonal techniques such as LC-MS for identity confirmation\, and the role of stability-indicating methods in maintaining product quality.
URL:https://thebiocalendar.com/event/analytical-strategies-for-high-volume-glp-1-manufacturing/
LOCATION:Online webinar
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/05/26_05_POLL_MedRectangle_300x250.png
END:VEVENT
END:VCALENDAR